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Kaposi’s sarcoma-associated human herpesvirus (KSHV) encodes a processivity factor (PF-8, ORF59) that forms homodimers and binds
to viral DNA polymerase (Pol-8, ORF9). PF-8 is essential for stabilizing Pol-8 on template DNA so that Pol-8 can incorporate nucleotides
continuously. Here, the intracellular interaction of these two viral proteins was examined by confocal immunofluorescence microscopy.
When individually expressed, PF-8 was observed exclusively in the nucleus, whereas Pol-8 was found only in the cytoplasm. However, when
co-expressed, Pol-8 was co-translocated with PF-8 into the nucleus. Mutational analysis revealed that PF-8 contains a nuclear localization
signal (NLS) as well as domains located at the N-terminus and the C-proximal regions that are required for Pol-8 binding. This study suggests
that the mechanism that enables PF-8 to transport Pol-8 into the nucleus is the first critical step required for Pol-8 and PF-8 to function
processively in KSHV DNA synthesis.
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Kaposi’s sarcoma-associated herpesvirus (KSHV), also
called human herpes virus-8 (HHV-8), is a gammaherpesvi-
rus with a double-stranded DNA genome of 165 kb (Russo
et al., 1996). In infected cells, many of the 80 KSHV genes
function in altering the cell cycle, preventing apoptosis, and
evading innate and adaptive immune responses (reviewed in
Moore and Chang, 2003). KSHV is linked to two B cell
disorders observed in AIDS: Primary Effusion Lymphoma or
PEL (Cesarman et al., 1995) and Multicentric Castleman’s
Disease or MCD (Soulier et al., 1995). During states of
immunosupression, KSHV frequently induces Kaposi’s
sarcoma (KS), recognized as the classic malignancy asso-
ciated with AIDS. Following primary lytic infection, a0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2005.06.017
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enabling them to grow indefinitely (Moore and Chang,
2003). Intriguingly, recent evidence suggests that, in KS
tumors, latently infected cells need to be continuously
replenished from a minor population of cells that are lytically
infected with KSHV (Grundhoff and Ganem, 2004; Ciufo et
al., 2001). Therefore, strategies aimed at blocking mecha-
nistic steps that are specific to KSHV replication could
provide new ways for eliminating these virally induced
human cancers.
KSHV encodes eight genes that participate in origin-
dependent DNA replication (Wu et al., 2001; AuCoin et al.,
2004). They include DNA polymerase (Pol-8, ORF9),
processivity factor (PF-8, ORF59), helicase (HEL,
ORF44), primase (PRI, ORF56), primase-associated factor
(ORF40/41), single-strand DNA binding protein (SSB,
ORF6), replication and transcription activator protein
(RTA, ORF 50), and replication-associated protein (RAP,
K8). Of particular interest is PF-8, which we discovered
and demonstrated to be essential for Pol-8 DNA synthesis05) 183 – 191
Y. Chen et al. / Virology 340 (2005) 183–191184(Lin et al., 1998). Previously, we had shown that Pol-8
alone incorporates only three nucleotides, whereas Pol-8
combined with PF-8 incorporates thousands of nucleotides
(Lin et al., 1998). This indicated that PF-8 can confer
processivity by enabling Pol-8 to incorporate nucleotides
continuously without dissociating from the DNA template
(Lin et al., 1998; Chen et al., 2004). Using a transient
cotransfection-replication assay, others have now corrobo-
rated that PF-8 is essential for KSHV origin replication
(AuCoin et al., 2004). While the actual mechanism of
KSHV processive DNA synthesis is unknown, it likely
involves PF-8 tethering Pol-8 to the DNA. In addition, we
have recently shown that PF-8 functions as a dimer in
processive DNA synthesis (Chen et al., 2004). This is
significant since it revealed for the first time that the
subunit composition of different herpesvirus processivity
factors are not all the same, in that processivity factor
UL42 of HSV-1 exists as a monomer (Randell and Coen,
2004) and processivity factor UL44 of CMV exists as a
dimer (Chen et al., 2004; Appleton et al., 2004).
One compelling question that emerges from these studies
is where and how Pol-8 and PF-8 associate in the cell. A
recent study (Wu et al., 2001) suggested that PF-8 is sufficient
to translocate Pol-8 into the nucleus. Here, we sought to
define the mechanism by which PF-8 might function as the
nuclear transporter of Pol-8. We show that, when expressed
individually, PF-8 resides exclusively in the nucleus, whereas
Pol-8 resides only in the cytoplasm. We report that PF-8
contains two domains that are required to bind to Pol-8 and a
nuclear localization signal (NLS) that serves to transport both
proteins into the nucleus. Our results indicate that, in additionFig. 1. PF-8 transports Pol-8 into the nucleus. (A) PF8-GFP and Flag-Pol8 cons
residues) and Flag-tag fused to the N-terminus of Pol-8 (1012 residues). (B) Conf
with PF8-GFP and Flag-Pol8. In both panels, nuclei were stained with DAPI (blue
image due to the overlapping fluorescent signal of PF8-GFP (green) and the DAP
cytoplasm by anti-Flag antibody. (C) Nuclear co-localization of PF8-GFP and Flag
and analyzed by confocal immunofluorescence microscopy. In the same nucleus, t
stained nuclei (blue, c), were assembled to generate a merged image (nearly whito enabling Pol-8 to function processively on the DNA, PF-8
also acts as the nuclear transporter of Pol-8.Results
PF-8 transports Pol-8 into the nucleus
We have shown in vitro that Pol-8 must associate with
PF-8 in order to synthesize DNA processively (Lin et al.,
1998; Chen et al., 2004). To gain an understanding of how
these proteins function in vivo, we investigated where Pol-8
and PF-8 reside in the cell when expressed alone and together.
To accomplish this, different tags were appended to the two
full-length proteins. A GFP (green fluorescent protein) was
fused to the C-terminus of PF-8, and a Flag-tag was fused to
the N-terminus of Pol-8 (Fig. 1A). These constructs were
transfected into Vero cells, and the subcellular localization of
the fusion proteins was examined after 24 h for autofluor-
escence from GFP or immunofluorescence from the secon-
dary antibody against anti-Flag antibody.
As shown in Fig. 1B (right panel), when transfected alone,
Flag-Pol8 was detected only in the cytoplasm as a punctate
pattern. By contrast, PF8-GFP alone was observed exclu-
sively in the nucleus as a diffuse signal (Fig. 1B, left panel).
Western blot analysis of lysates from transfected cells, using
cytoplasmic (h-actin) and nuclear (retinoblastoma protein)
markers, confirmed the Pol-8 and PF-8 partition into
cytoplasmic and nuclear compartments, respectively (Fig.
2A). The tags did not appear to have an adverse affect on the
functioning, and hence, folding of these proteins since Flag-tructs. Depicted are GFP fused to the C-terminus of full-length PF-8 (396
ocal immunofluorescence microscopy of Vero cells transfected individually
). In the left panel, PF8-GFP appears in one of the nuclei as a cyanic-colored
I dye (blue). In the right panel, Flag-Pol8 is detected as a red image in the
-Pol8. Vero cells were co-transfected with PF8-GFP and Flag-Pol8 plasmids
he individual images of PF8-GFP (green, a), Flag-Pol8 (red, b), and DAPI-
te, d). The scale bar represents 20 Am.
Fig. 2. Cellular partitioning and processive DNA synthesis of tagged Pol-8
and PF-8. (A) PF8-GFP fractionates in the nucleus and Flag-Pol8 in the
cytoplasm. Vero cells were transfected with PF8-GFP or Flag-Pol8
plasmids and, after 48 h, were lysed and separated into cytosolic (C) and
nuclear (N) fractions. The proteins from the C and N fractions were
separated by PAGE and analyzed by immunoblotting with (I) anti-PF8
serum and anti-Flag monoclonal antibody or (II) the cytoplasmic marker h-
actin or (III) the nuclear marker retinoblastoma (pRB). (B) PF8-GFP and
Flag-Pol8 function in processive DNA synthesis. Tagged and untagged PF-
8 and Pol-8 were analyzed alone or in different combinations in the DNA
synthesis M13 processivity assay. The band at >7000 nt indicates a labeled
DNA product obtained by processive DNA synthesis from the primed M13
single-strand DNA template.
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length 7249 nt DNA molecule as their untagged counterparts
(Fig. 2B). In particular, this indicated that the inability of
Flag-Pol8 to translocate into the nucleus in the absence of
PF8-GFP is an inherent feature of Pol-8 and is not attributable
to the eight-amino acid Flag tag.
We then microscopically examined the location of both
proteins when Pol-8 and PF-8 were co-transfected. As seen
in Fig. 1C, the localization of Flag-Pol8 was shifted
completely from the cytoplasm into the nucleus (panel b)
in the presence of PF8-GFP (panel a). The white merged
image (panel d) represents the co-localization of PF8-GFP
(green), Flag-Pol8 (red) inside the same nucleus (blue).
These results suggested that PF-8 associates with Pol-8 in
the cytoplasm and that PF-8 provides a signal that is used to
transport both proteins into the nucleus.
PF-8 is targeted to the nucleus by a C-terminal NLS
To determine if PF-8 contains a specific region that
directs this processivity factor into the nucleus, four PF-8
deletion mutants tagged with GFP (Fig. 3A, upper panel)
were constructed and individually transfected into Vero
cells. The protein products of these deletion mutants were of
the expected size (Fig. 3A, lower panel). As shown in Fig.
3B, unlike wild type PF-8 (PFWT) (panel a), the C-terminaldeletion mutant PF1–65 (panel b) was incapable of entering
the nucleus. By contrast, the two N-terminal deletion
mutants PF271–396 and PF366–396 (panels c and d) and the
internal deletion mutant PFN–C (panel e) appeared to be as
efficient as PFWT in their abilities to translocate into the
nucleus. These results provided evidence that the last 30
amino acids of PF-8 (residues 366–396) are sufficient to
translocate PF-8 into the nucleus.
We then inquired whether full-length PF-8 contains an
NLS by computational analysis using the PSORT program
(Nakai and Horton, 1999; Hicks and Raikhel, 1995).
Consistent with the above result, computational analysis
suggested that the C-terminus of PF-8 contains a sequence,
369KRPHKRRSD377, which has features of an NLS. To
establish whether this putative NLS contains residues
critical for PF-8 nuclear translocation, we generated a
series of alanine substitutions within 369KRPHKRRSD377,
in the context of full-length PF-8, as depicted in Fig. 4A.
Subcellular localization of the mutant proteins was
examined following transfection of the substitution con-
structs into Vero cells. Each panel in Fig. 4B displays a
single Vero cell that is representative of approximately 200
cells expressing a mutant PF-8 protein. For each cell, the
signals from the nuclear DNA DAPI dye (blue) and the
GFP autofluorescence (green) are merged (cyan). The GFP
control, designated as GFP-VEC, distributed evenly
throughout the cell (panel a), in contrast to PFWT that
translocated completely into the nucleus (panel b).
Interestingly, the effect of substituting the two basic N-
terminal amino acid residues (lysine 369 and arginine 370)
in the double mutant KR369–370AA did not hinder PF-8
from translocating into the nucleus (panel c). Furthermore,
the substitution of proline 371 in the point mutant P371A
had a negligible effect on nuclear translocation of PF-8
(panel d). By contrast, co-substitution of the three
contiguous basic amino acids KRR (residues 373–375)
to AAA had the most profound disabling effect on nuclear
translocation, as observed by significant retention of this
mutant PF-8 protein (KRR373–375AAA) in the cytoplasm
(panel h). When examined individually, the single sub-
stitution mutants K373A (panel e), R374A (panel f), and
R375A (panel g) were disabled in nuclear translocation to a
comparable extent as the triple mutant KRR373–375AAA
(Figs. 4A and B). These results indicated that the C-
terminal region of full-length PF-8 contains an NLS that
comprises contiguous basic amino acids essential for
efficient nuclear translocation.
To establish that 369KRPHKRRSD377 of PF-8 is suffi-
cient to function as an NLS, this nine-amino acid sequence
was appended to the N-terminus of GFP. This NLS-GFP
plasmid was transfected into Vero cells that were then
examined for autofluorescence. As shown in Fig. 5, NLS-
GFP appeared predominantly in the nucleus (panels a–c),
whereas the GFP control (GFP-VEC) diffused throughout
the entire cell (panel d–f), indicating that this nine-amino
acid sequence has the capacity to function as an NLS.
Fig. 3. The C-terminus of PF-8 encodes a signal for nuclear targeting. (A) Structures of wild type and deletion mutants of PF-8 fused to GFP. (B) Subcellular
localization of mutant PF-8 GFP fusion proteins. The PF-8 GFP fusion protein appears green in the cytoplasm (b) but cyanic-colored in the nuclei (a and c–e)
due to overlapping of fluorescent signals from PF-8 GFP protein (green) with DAPI-stained nuclei (blue). The scale bar represents 20 Am.
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terminal region of PF-8 encodes an NLS within the
sequence 369KRPHKRRSD377, which is required for nuclear
localization of PF-8. Nuclear localization of full-length PF-8
is dependent upon the three basic contiguous residues (KRR)
within the NLS. Definitive proof that 369KRPHKRRSD377
functions as an NLS was the ability of these nine residues to
bestow nuclear translocation to a foreign protein.
Domains of PF-8 required for binding Pol-8 for transport
into the nucleus
In our previous study, an in vitro analysis of PF-8
mutants suggested that the PF-8 N-terminal region (resi-
dues 1–21) and C-proximal region (residues 277–304) areinvolved in binding Pol-8 (Chen et al., 2004). To further
investigate how PF-8 is able to transport Pol-8 into the
nucleus (Fig. 1C), we analyzed the subcellular localization
of Pol-8 in the presence of the PF-8 mutants depicted in
Fig. 3A. Flag-tagged Pol-8 and mutant PF8-GFP constructs
were co-transfected into Vero cells, and the fluorescent
signals were viewed independently and merged. As shown
in Fig. 6 (panels a–d), Pol-8 completely translocated into
the nucleus in the presence of PFWT as expected. However,
when PF1–65 (panels e–h), which lacks the PF-8 NLS, was
co-transfected with Pol-8, neither the mutant PF-8 protein
nor the Pol-8 protein was observed in nuclei. Interestingly,
the NLS-containing PF271–396 (panels i–l) was able to
transport Pol-8 into the nucleus. By contrast, the NLS-
containing PF366–396 (panels m–p) translocated into the
Fig. 4. PF-8 contains an NLS with contiguous basic amino acids that are critical for nuclear translocation. (A) NLS mutants of PF-8. Depicted are the position
and amino acid sequence of the NLS encoded within full-length wild type PF-8. Represented in bold and underlined are amino acid substitutions that were
introduced into the NLS of full-length PF-8 fused to GFP. The plus and minus designations refer to distribution of nuclear and cytoplasmic wt and mutated
PF8-GFP proteins relative to the GFP-VEC standard which is set to () for nuclear and (++++) for cytoplasmic staining. (B) Subcellular localization of NLS
substitution mutants of PF-8. Vero cells were transfected with PFWT (b), control VEC-GFP (a), and the PF-8 NLS substitution mutant plasmids (c–h). After 24 h,
cells were fixed and images were captured by confocal microscopy. Nuclei appear cyanic-colored when the fluorescent signals from PF-8 GFP protein (green)
overlap with DNA DAPI dye (blue). The scale bar represents 20 Am.
Y. Chen et al. / Virology 340 (2005) 183–191 187nucleus while Pol-8 remained in the cytoplasm, indicating
that the PF-8 NLS is necessary but not sufficient for
transporting Pol-8 into the nucleus. Importantly, nuclear
transport of Pol-8 by PF271–396 but not by PF366–396
suggested that PF-8 contains a C-proximal Pol-8 binding
region (residues 271–365). Significantly, PFN–C (panels q–
t), which contains the N-terminal 21 amino acids of PF-8
fused to the NLS-containing C-terminal region (residues
366–396), was able to support nuclear translocation of Pol-8.
Collectively, these results establish that the nuclear transport
of Pol-8 is achieved through its association with PF-8,
requiring the N-terminal and/or C-proximal regions of this
processivity factor. The C-terminal NLS of PF-8 thenmediates transport of its bound Pol-8 passenger into the
nucleus.Discussion
In this study, we have shown that, in the absence of PF-8,
Pol-8 remains exclusively in the cytoplasm. We have
identified an NLS in the C-terminus of PF-8 that accounts
for the exclusive nuclear localization of this protein. This
NLS 369KRPHKRRSD377 has three contiguous basic amino
acids (KRR) that are critical for nuclear localization of PF-8.
The transport Pol-8 into the nucleus was shown to depend
Fig. 5. Appendage of the NLS peptide of PF-8 to GFP provides nuclear transport. Fluorescence analysis of NLS-GFP. Depicted to the left of the panels are the
NLS-GFP fusion peptide, which comprises nine amino acids from the putative NLS of PF-8 appended to the N-terminus of GFP, and unmodified GFP that was
used as a control. Merged images (c and f) were assembled from individual images of GFP (a and d) and DAPI (b and e). The scale bar represents 20 Am.
Y. Chen et al. / Virology 340 (2005) 183–191188on this NLS as well as the N-terminus or C-proximal
regions of PF-8 that are required for Pol-8 binding. In this
regard, PF-8 is the first processivity factor reported to co-
transport its DNA polymerase into the nucleus.
Processivity factors of several other human herpesvi-
ruses including UL42 of HSV-1 (Goodrich et al., 1989),
BMRF1 of EBV (Kiehl and Dorsky, 1991), UL44 of
HCMV (Plachter et al., 1992), p41 of HHV-6 (Agulnick et
al., 1993), and U27 of HHV-7 (Takeda et al., 2000) are
observed to localize in nuclei. Although the processivity
factors U27 and BMRF-1 (Takeda et al., 2000; Zhang et
al., 1999) have each been shown to contain a functional
NLS, it remains to be demonstrated whether they also
serve to co-transport their respective DNA polymerases
into nuclei. A recent study suggests that the DNA
polymerases of some herpesviruses may not rely on their
cognate processivity factors for nuclear transport (Lore-
gian et al., 2000). Specifically, peptides corresponding to
the C-terminal residues of the DNA polymerases of HSV-1
(UL30), HCMV (UL54) and EHV-1 (ORF30) were shown
to function as an NLS when fused to h-galactosidase
(Loregian et al., 2000). Unlike UL30 and UL54 DNA
polymerases, computational analysis indicates that POL-8 is
devoid of an apparent NLS in its C-terminus. Interestingly,
Pol-8 is 223 amino acids shorter and has 34 fewer amino
acids on its C-terminus than the well-characterized UL30.
This computational analysis alone suggests that Pol-8
translocates to the nucleus by a mechanism that is distinct
from that of UL30. Indeed, our data, which show a reliance
on PF-8 association for nuclear translocation of Pol-8, are
consistent with this prediction. It thus remains to be
established whether the DNA polymerases of other human
herpesviruses also utilize their processivity factors for
nuclear translocation.Nuclear co-translocation of PF-8 and Pol-8 likely
provides a means for coordinating their recognition of
DNA and facilitating processive DNA synthesis. In this
regard, it is possible that the formation of the natural
KSHV lytic origin of replication complex that includes
single-stranded DNA binding protein (SSB, ORF6), heli-
case (HEL, ORF44), primase (PRI, ORF56), and primase-
associated factor (ORF40/41) depends upon the cytoplas-
mic association of PF-8 and Pol-8 as a preassembly step
(Wu et al., 2001, AuCoin et al., 2004). Interestingly, in
HSV-1-infected cells, the formation of complete replica-
tive structures was shown to depend on the ordered
assembly of the DNA polymerase/processivity factor
(UL30/UL42) heterodimer with prereplicative site struc-
tures that include helicase, primase, origin binding protein,
and single-stranded DNA binding protein (Liptak et al.,
1996; Burkham et al., 1998; Carrington-Lawrence and
Weller, 2003).
We have found here that the N-terminal and C-proximal
domains of PF-8 are sufficient for independently trans-
porting Pol-8 into the nucleus as long as the PF-8 NLS is
present. Our previous work demonstrated that PF-8
requires both the N-terminal and C-proximal domains to
function as a dimer in processive DNA synthesis (Chen
et al., 2004). It is thus interesting to consider that PF-8
monomers might be capable of transporting Pol-8 into the
nucleus since PF-8 mutants lacking either the N-terminal or
C-proximal domains are still able to fulfil this transport
function. Future studies will establish whether monomers or
dimers of PF-8 naturally serve to transport PF-8 into the
nucleus.
Viral processivity factors are attractive drug targets
since they are essential for viral DNA synthesis. The dual
ability of PF-8 to stabilize Pol-8 on the DNA and to
Fig. 6. The N-terminal and C-proximal regions of PF-8 are required for nuclear transport of Pol-8. Co-expression of Flag-Pol8 and mutant PF-8 GFP fusion
proteins was analyzed by confocal immunofluorescence microscopy. Indicated at the left of the panels are Flag-Pol8 co-expressed with PFWT (a–d); PF1 – 65
(e–h); PF271 – 396 (i – l); PF366 – 396 (m–p); and PFN–C (q– t). Merged images were assembled from individual images (GFP, anti-Flag, and DAPI). The scale bar
represents 20 Am.
Y. Chen et al. / Virology 340 (2005) 183–191 189transport Pol-8 into the nucleus expands the venues by
which this critical KSHV protein can be inhibited.
Therapeutics that disrupt the interaction of PF-8 with
Pol-8 could serve to block both nuclear transport and
processivity and thereby effectively prevent replication of
KSHV.Materials and methods
Plasmids and mutagenesis
PCR fragments of full-length or truncated PF-8 were
cloned into the unique BamHI and XbaI sites of pEGFP-N1
(BD Biosciences, Palo Alto, CA) in order to make a series
of GFP fusion proteins in which GFP was appended to the
C-terminus of PF-8. Site-directed mutagenesis of PF-8 was
carried out with Quick Change Kit (Stratagene, La Jolla,
CA). PCR primers are listed in Table 1. The Flag-Pol8construct was generated by inserting a PCR fragment
encoding N-terminal Flag-tagged Pol-8 into pcDNA3.1/
V5-His-TOPO (Invitrogen, Carlsbad, CA). The PCR pri-
mers for Flag-Pol8 were:
5V-CACCGCCACCATGGATTACAAGGATGACGAC-
GATAAGATGGATTTTTTCAATCCATTTATC-
GACCC-3V and 5V-CTAGGGCGTGGGAAAAGTCAC-
GGGAATGTC-3V.
NLS-GFP was constructed by using Exsite PCR-based
Site-Directed strategy with primers
5 V-AGGCGCTCAGACGCCACCATGGTGAG-
CAAGGGCGAGGAGC-3V and 5V-CTTGTGAGGCCT-
CTTCATGGTGGCGGCGACCGGTGGATCCCGGG-
CCCGCGGTACCGTC-3V.
All DNA constructs were verified by DNA sequencing.
Table 1
PCR primers for generating wild type and mutant PF8-GFP fusion proteins
Constructs Primers
PFWT 5V-GCTCAAGCTTGCCGCCACCATGCCTGTGGATTTTCACTATGGGG
5V-GACCGGTGGATCCACAATCAGGGGGTTAAATGTGGTTTTGGG
PF1– 65 5V-GCTCAAGCTTGCCGCCACCATGCCTGTGGATTTTCACTATGGGG
5V-GACCGGTGGATCCACGGCATTCTTTATTCTTAACCCCAG
PF271 – 396 5V-GCTCAAGCTTGCCGCCACCATGTGGCACTCCAACGAAATATTAGAAG
5V-GACCGGTGGATCCACAATCAGGGGGTTAAATGTGGTTTTGG
PF366 – 396 5V-GACAGCACAAAGAGGCCTCACAAGAGGCGCTC
5V-CATGGTGGCGGCAAGCTTGAGCTCGAGATCTGAGTCC
PFN–C 5V-CCTCCTGATTTTAGACAGGAGGGTCACGTC
5V-GACAGCACAAAGAGGCCTCACAAGAGGCGCTC
KR369 – 370AA 5V-CCAACTAAGGACAGCACAGCCGCCCCTCACAAGAGGCGCTCAGAC
5V-GTCTGAGCGCCTCTTGTGAGGGGCGGCTGTGCTGTCCTTAGTTGG
P371A 5V-GCACAAAGAGGGCCCACAAGAGGCGCTCAGACTCG
5V-CGAGTCTGAGCGCCTCTTGTGGGCCCTCTTTGTGC
K373A 5V-CACAAAGAGGCCTCACGCCAGGCGCTCAGACTCG
5V-CGAGTCTGAGCGCCTGGCGTGAGGCCTCTTTGTG
R374A 5V-GCACAAAGAGGCCTCACAAGGCCCGCTCAGACTCGAGCCAG
5V-CTGGCTCGAGTCTGAGCGGGCCTTGTGAGGCCTCTTTGTGC
R375A 5V-GCCTCACAAGAGGGCCTCAGACTCGAGCCAGTCCAG
5V-CTGGACTGGCTCGAGTCTGAGGCCCTCTTGTGAGGC
KRR369 – 370AAA 5V-CAAAGAGGCCTCACGCCGCCGCCTCAGACTCGAGCCAGTCCAGGGATCGTGG
5V-CCACGATCCCTGGACTGGCTCGAGTCTGAGGCGGCGGCGTGAGGCCTCTTTG
Y. Chen et al. / Virology 340 (2005) 183–191190Cell culture and DNA transfection
Vero cell lines were cultured under 5% CO2 at 37 -C in
Dulbecco’s modified Eagle’s medium (DMEM) supple-
mented with 5% fetal bovine serum and gentamycin
(Invitrogen, Carlsbad, CA). Cells used for immunofluores-
cence assay were seeded onto 12-mm glass coverslips
(Fisherbrand) in 24-well plates at a density of 5  104 cells
per well. Transient transfection was carried out with Lip-
ofectamin2000 (Invitrogen, Carlsbad, CA).
Western blot analysis
Nuclear and cytosolic cell extracts were prepared from
washed cell pellets (Hasegawa et al., 1999). Twenty micro-
grams of protein from the extracts was fractionated on a 10%
SDS polyacrylamide gel, transferred to PVDF membrane
(Millipore), and probed with anti-PF8 serum or peroxidase-
conjugated anti-Flag-antibody (Sigma, St. Louis, MO). The
Western blots were also probed with anti-Rb (Abcam Inc.,
Cambridge, MA) and anti-h-actin (Sigma, St. Louis, MO) to
evaluate the separation of the nuclear and cytoplasmic
fractions, respectively.
Indirect immunofluorescence and confocal microscopy
Twenty-four hours after transfection, cells on glass
coverslips were washed with phosphate-buffered saline
(PBS), fixed with paraformaldehyde (3% [vol/vol] in
PBS), and then permeabilized with 0.2% TX-100 in PBS.
The coverslips were blocked with 3% BSA in PBS for
30 min. Detection of Flag-Pol8 was performed by
indirect immunofluorescence using biotin-labeled mono-clonal anti-Flag antibody (Sigma, St. Louis, MO) and
streptavidin-conjugated Alexa-555 (Invitrogen, Carlsbad,
CA) diluted 1:100 and 1:500, respectively, in blocking
buffer. The cells were also counterstained with DAPI
(Sigma, St. Louis, MO) to detect nuclei. The cells were
then mounted in anti-fade agent (Invitrogen, Carlsbad,
CA) and visualized with a Nikon confocal microscope
(Eclipse TE300; 40 objective lens; numerical aperture,
1.3) equipped with Radiance2000 (BIO-RAD) and soft-
ware lasersharp2000 (BIO-RAD). Image files were
exported in TIF format for processing with Photoshop.
Each experiment was repeated at least three times.
DNA synthesis processivity assay
PF-8 or PF8-GFP and Pol-8 or Flag-Pol8 were expressed
from plasmids using an in vitro T7-TNT coupled tran-
scription– translation system (Promega) as previously
described (Lin et al., 1998; Chen et al., 2004). The proteins
were tested for their abilities to synthesize DNA from an 18 nt
M13 primer annealed M13 ssDNA template (7249 nt) in the
presence of dATP, dGTP, dTTP, and 10 AM [32P]dCTP (3000
Ci/mmol; NEN), and the labeled DNA products were
fractionated on a 1.3% alkaline agarose gel and analyzed
by autoradiography as previously described (Lin et al., 1998;
Chen et al., 2004).Acknowledgments
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